PETMED EXPRESS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
PETMED EXPRESS, INC. (PETS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 27.00 thousand shares for the 12-month period ending 2023-03-31, per its 10-K/A filed 2024-04-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2024-04-15
- PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2023 was 27.00K shares, a 170.00% increase from fiscal 2022.
- PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2022 was 10.00K shares, a 233.33% increase from fiscal 2021.
- PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2021 was 3.00K shares, a 66.67% decline from fiscal 2020.
- PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2020 was 9.00K shares, a 25.00% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month |
|---|---|
| 2023-03-31 | 27.00K shares 10-K/A · filed 2024-04-15 |
| 2022-03-31 | 10.00K shares 10-K · filed 2022-05-24 |
| 2021-03-31 | 3.00K shares 10-K · filed 2021-05-25 |
| 2020-03-31 | 9.00K shares 10-K · filed 2020-05-26 |
| 2019-03-31 | 12.00K shares 10-K · filed 2019-05-28 |
| 2018-03-31 | 4.00 shares 10-K · filed 2018-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |